Learn More
Invitrogen™ OPRM1 Recombinant Rabbit Monoclonal Antibody (13H5L13)
Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. Recombinant antibodies are produced using specific genes that code for the desired antibodies. These genes are cloned into an expression vector and expressed in vitro. The advantages of recombinant antibodies include better specificity and lot-to-lot consistency. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
Specifications
Specifications
| Antigen | OPRM1 |
| Applications | Immunohistochemistry, Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 13H5L13 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.2-7.4 |
| Gene | OPRM1 |
| Gene Accession No. | P33535, P35372 |
| Gene Alias | hMOP; KIAA0403; LMOR; MOP; MOP receptor; MOP-R; Mor; MOR1; M-OR-1; MOR-1; MOR-1C; MOR-1O; MORA; Mu opiate receptor; mu opioid receptor; mu opioid receptor hMOR-1a; mu opioid receptor splice variant mMOR-1Z; mu opioid receptor splice variant rMOR-1S; mu opioid receptor splice variant rMOR-1Z; mu-opioid receptor; muOR; MUOR1; mu-type opioid receptor; Opioid mu receptor; Opioid Receptor; opioid receptor B; opioid receptor mu 1; opioid receptor, mu 1; OPRM; Oprm1; Oprrm1; OTTHUMP00000017463; Ror-b |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.